D. Noel

1.1k total citations
10 papers, 360 citations indexed

About

D. Noel is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Noel has authored 10 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Hematology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Noel's work include Cancer Treatment and Pharmacology (5 papers), Neutropenia and Cancer Infections (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). D. Noel is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Neutropenia and Cancer Infections (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). D. Noel collaborates with scholars based in United States, India and Canada. D. Noel's co-authors include K Atkinson, Thomas Ed, Katherine Sullivan, PL Weiden, RP Witherspoon, R Storb, John R. Mackey, Taher Al‐Tweigeri, Michael Smylie and A. Riva and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Journal of Cancer.

In The Last Decade

D. Noel

9 papers receiving 338 citations

Peers

Countries citing papers authored by D. Noel

Since Specialization

Citations

This map shows the geographic impact of D. Noel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Noel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Noel more than expected).

Fields of papers citing papers by D. Noel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Noel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Noel. The network helps show where D. Noel may publish in the future.

Co-authorship network of co-authors of D. Noel

This figure shows the co-authorship network connecting the top 25 collaborators of D. Noel. A scholar is included among the top collaborators of D. Noel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Noel. D. Noel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer 2001 ·Journal of Clinical Oncology ·Jean‐Marc Nabholtz, John R. Mackey, Michael Smylie, Alexander Paterson, D. Noel, Taher Al‐Tweigeri, Katia Tonkin, Scott North, N. Azli, A. Riva	91
2	Final results of a phase II study of Taxotere (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in thétreatment of metastatic breast cancer (MBC) 1998 ·European Journal of Cancer ·J.-M. Nabholtz, John R. Mackey, (unknown), Alexander Paterson, D. Noel, (unknown), Anna Janowska‐Wieczorek, (unknown), A. Riva	1
3	Taxotere™ (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC) 1997 ·European Journal of Cancer ·J.-M. Nabholtz, (unknown), John R. Mackey, Alexander Paterson, D. Noel, (unknown), (unknown), (unknown), F. Delorme, A. Riva	4
4	Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer. 1997 ·PubMed ·J.-M. Nabholtz, Michael Smylie, John R. Mackey, (unknown), D. Noel, Taher Al‐Tweigeri, (unknown), F. Delorme, A. Riva, (unknown)	24
5	P953. Phase II study of taxotere® (Docetaxel, D), Doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC) 1997 ·The Breast ·J.-M. Nabholtz, John R. Mackey, Michael Smylie, Alexander Paterson, D. Noel, Taher Al‐Tweigeri, F. Delorme	5
6	RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTING 1984 ·Transplantation ·Robert P. Witherspoon, David A. Matthews, Rainer Storb, K Atkinson, Martin A. Cheever, H. Joachim Deeg, K Doney, J. G. Kalbfleisch, D. Noel, Ross L. Prentice, Keith M. Sullivan, E. Donnall Thomas	52
7	Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting 1983 ·British Journal of Haematology ·Robert P. Witherspoon, J. Hersman, Rainer Storb, HD Ochs, Allan L. Goldstein, John E. McClure, D. Noel, P L Weiden, E. Donnall Thomas	15
8	Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting 1983 ·British Journal of Haematology ·Robert P. Witherspoon, J. Hersman, Rainer Storb, HD Ochs, Allan L. Goldstein, John E. McClure, D. Noel, P L Weiden, E. Donnall Thomas	7
9	Analysis of late infections in 89 long-term survivors of bone marrow transplantation 1979 ·Blood ·K Atkinson, R Storb, (unknown), PL Weiden, RP Witherspoon, Katherine Sullivan, D. Noel, Thomas Ed	146
10	The effect of graft-versus-host disease on reconstitution of the immune system following marrow transplantation for aplastic anemia or leukemia. 1978 ·PubMed ·Robert Witherspoon, D. Noel, Rainer Storb, HD Ochs, Thomas Ed	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact